drugset / Trial / NCT00508469

Adherence Assessment With Travalert Dosing Aid

NCT00508469

Phase 4 Completed 102 enrolled Alcon Research
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare adherence in patients on a fixed combination of travoprost 0.004%/timolol 0.5% and patients on a concomitant combination of travoprost 0.004% and timolol 0.5% using the Travalert® device.

Timeline

Start
2007-10
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Timolol Other / unclassified 0.05 % Other
Subject Timolol Other / unclassified 0.5 % Other
Subject Travoprost Other / unclassified 0.004 % Other